Briefing
Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer
Completed phase 3 DART trial (n=228) of de-escalated adjuvant RT plus docetaxel versus standard adjuvant RT in HPV-associated OPSCC. ctHPVDNA MRD was not used to assign treatment; a 140-patient secondary analysis is PMID 40402484.
- Design: Phase 3 · Completed